Samuel Levy

Samuel Levy is a founding partner at Lauxera Capital Partners, an asset management firm specializing in healthcare growth companies. Currently, Levy serves on the boards of several innovative companies including Acandis GmbH, Natural Cycles°, OrganOx, Matrix Requirements, Veranex, and Reapplix, contributing expertise in medical technology and regenerative medicine. Additionally, Levy is a board observer at eGenesis, Inc., focusing on solutions for organ transplantation. As the founder of Allurion Technologies, Levy developed groundbreaking devices for the weight loss industry, including the world’s first procedureless gastric balloon. Levy holds an MD from Harvard Medical School and a BS in Molecular Biophysics and Biochemistry from Yale University.